探讨Ⅱ期宫颈癌术前介入治疗的临床价值  

作　　者：赵毅[1] 陈思争[1] 刘红权[1] 王治杰[1] 万军[1] 

机构地区：[1]河南永城市人民医院,476600

出　　处：《中国社区医师（医学专业）》2012年第2期179-179,共1页

摘　　要：目的:探讨Ⅱ期宫颈癌患者术前介入治疗的临床价值。方法:术前经介入化疗栓塞治疗Ⅱ期宫颈癌患者34例,术前采用动脉插管化疗而后行双侧髂内动脉栓塞,患者年龄29～68岁,平均50.5岁。结果:34例经过介入化疗后10～14天后病灶体积缩小明显,达到手术治疗的指征,所有患者均获得手术机会,术中出血明显减少,34例患者术后病理示部分瘤细胞变性、坏死,瘤细胞数量减少。清扫的盆腔淋巴结数平均19～23个,病理未发现转移。结论:子宫动脉化疗栓塞是Ⅱ期宫颈癌术前有效的辅助治疗手段。Objective ：To investigate Ⅱ cervical cancer patients before intervention clinical value. Methods：In our hospital in January 2008 - March 2011 preoperative interventional embolization therapy in patients with cervical cancer stageⅡ , 34 cases of preoperative use of arterial chemotherapy and then underwent bilateral internal iliac artery embolization, patients aged 29 to 68 years, mean 50.5 years old. Results ： the resuits of 34 intervention 14 days after chemotherapy,10 significantly reduced tumor volume to reach surgical treatment indications, all patients have received the chance of operation, blood loss was significantly reduced, 34 patients showed some pathological tumor cell degeneration, necrosis, reduce the number of tumor ceils. The average number of pelvic lymph node dissection is 19 to 23 months, the transfer of pathology found. Conclusions： Uterine artery embolization is an effective preoperative cervical cancer Ⅱ aid treatment.

关 键 词：宫颈肿瘤 血管造影术 栓塞术 

分 类 号：R735.2[医药卫生—肿瘤]